SBI Securities Co. Ltd. Acquires New Position in Vir Biotechnology, Inc. (NASDAQ:VIR)
SBI Securities Co. Ltd. bought a new position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 8,222 shares of the company’s stock, valued at approximately $60,000. Other large investors also recently bought and sold […]
